These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29266204)

  • 1. Hepatitis C virus core protein reduces CD8
    Khan ST; Karges W; Cooper CL; Crawley AM
    Immunology; 2018 May; 154(1):156-165. PubMed ID: 29266204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection.
    Burke Schinkel SC; Carrasco-Medina L; Cooper CL; Crawley AM
    PLoS One; 2016; 11(6):e0157055. PubMed ID: 27315061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8
    Vranjkovic A; Deonarine F; Kaka S; Angel JB; Cooper CL; Crawley AM
    Front Immunol; 2019; 10():1926. PubMed ID: 31456810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
    Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
    Wedemeyer H; He XS; Nascimbeni M; Davis AR; Greenberg HB; Hoofnagle JH; Liang TJ; Alter H; Rehermann B
    J Immunol; 2002 Sep; 169(6):3447-58. PubMed ID: 12218168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model.
    Lukens JR; Cruise MW; Lassen MG; Hahn YS
    J Immunol; 2008 Apr; 180(7):4875-84. PubMed ID: 18354211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infection.
    Vranjkovic A; Crawley AM; Patey A; Angel JB
    J Leukoc Biol; 2011 Apr; 89(4):499-506. PubMed ID: 21177484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells.
    Lucas M; Vargas-Cuero AL; Lauer GM; Barnes E; Willberg CB; Semmo N; Walker BD; Phillips R; Klenerman P
    J Immunol; 2004 Feb; 172(3):1744-53. PubMed ID: 14734757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-derived hepatitis C virus inhibits CD4⁺ but not CD8⁺ T lymphocyte proliferation in primary T cells.
    MacParland SA; Chen AY; Corkum CP; Pham TN; Michalak TI
    Virol J; 2015 Jun; 12():93. PubMed ID: 26084511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection.
    Penna A; Pilli M; Zerbini A; Orlandini A; Mezzadri S; Sacchelli L; Missale G; Ferrari C
    Hepatology; 2007 Mar; 45(3):588-601. PubMed ID: 17326153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions.
    Kang W; Sung PS; Park SH; Yoon S; Chang DY; Kim S; Han KH; Kim JK; Rehermann B; Chwae YJ; Shin EC
    Gastroenterology; 2014 May; 146(5):1351-60.e1-4. PubMed ID: 24486950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic capacity of hepatitis C virus (HCV)--specific lymphocytes after in vitro immunization with HCV-derived lipopeptides.
    Langhans B; Schweitzer S; Braunschweiger I; Schulz M; Sauerbruch T; Spengler U
    Cytometry A; 2005 May; 65(1):59-68. PubMed ID: 15800857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4⁺CD28null T lymphocytes resemble CD8⁺CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients.
    Echeverría A; Moro-García MA; Asensi V; Cartón JA; López-Larrea C; Alonso-Arias R
    J Leukoc Biol; 2015 Sep; 98(3):373-84. PubMed ID: 26034206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
    Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
    J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C.
    Urbani S; Boni C; Missale G; Elia G; Cavallo C; Massari M; Raimondo G; Ferrari C
    J Virol; 2002 Dec; 76(24):12423-34. PubMed ID: 12438568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling.
    Radziewicz H; Ibegbu CC; Hon H; Bédard N; Bruneau J; Workowski KA; Knechtle SJ; Kirk AD; Larsen CP; Shoukry NH; Grakoui A
    J Immunol; 2010 Mar; 184(5):2410-22. PubMed ID: 20100932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus core protein-induced miR-93-5p up-regulation inhibits interferon signaling pathway by targeting IFNAR1.
    He CL; Liu M; Tan ZX; Hu YJ; Zhang QY; Kuang XM; Kong WL; Mao Q
    World J Gastroenterol; 2018 Jan; 24(2):226-236. PubMed ID: 29375208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.
    Boettler T; Spangenberg HC; Neumann-Haefelin C; Panther E; Urbani S; Ferrari C; Blum HE; von Weizsäcker F; Thimme R
    J Virol; 2005 Jun; 79(12):7860-7. PubMed ID: 15919940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.
    Ren JP; Zhao J; Dai J; Griffin JW; Wang L; Wu XY; Morrison ZD; Li GY; El Gazzar M; Ning SB; Moorman JP; Yao ZQ
    Immunology; 2016 Aug; 148(4):377-86. PubMed ID: 27149428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low perforin expression of early differentiated HCV-specific CD8+ T cells limits their hepatotoxic potential.
    Jo J; Bengsch B; Seigel B; Rau SJ; Schmidt J; Bisse E; Aichele P; Aichele U; Joeckel L; Royer C; Sá Ferreira K; Borner C; Baumert TF; Blum HE; Lohmann V; Fischer R; Thimme R
    J Hepatol; 2012 Jul; 57(1):9-16. PubMed ID: 22425625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.